Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.
Loading...
Embargo End Date
Authors
Abubakar, M
Chang-Claude, J
Ali, HR
Chatterjee, N
Coulson, P
Daley, F
Blows, F
Benitez, J
Milne, RL
Brenner, H
Stegmaier, C
Mannermaa, A
Rudolph, A
Sinn, P
Couch, FJ
Devilee, P
Tollenaar, RAEM
Seynaeve, C
Figueroa, J
Lissowska, J
Hewitt, S
Hooning, MJ
Hollestelle, A
Foekens, R
Koppert, LB
kConFab Investigators,
Bolla, MK
Wang, Q
Jones, ME
Schoemaker, MJ
Keeman, R
Easton, DF
Swerdlow, AJ
Sherman, ME
Schmidt, MK
Pharoah, PD
Garcia-Closas, M
Chang-Claude, J
Ali, HR
Chatterjee, N
Coulson, P
Daley, F
Blows, F
Benitez, J
Milne, RL
Brenner, H
Stegmaier, C
Mannermaa, A
Rudolph, A
Sinn, P
Couch, FJ
Devilee, P
Tollenaar, RAEM
Seynaeve, C
Figueroa, J
Lissowska, J
Hewitt, S
Hooning, MJ
Hollestelle, A
Foekens, R
Koppert, LB
kConFab Investigators,
Bolla, MK
Wang, Q
Jones, ME
Schoemaker, MJ
Keeman, R
Easton, DF
Swerdlow, AJ
Sherman, ME
Schmidt, MK
Pharoah, PD
Garcia-Closas, M
Document Type
Journal Article
Date
2018-08-15
Date Accepted
2018-01-26
Abstract
Limited epidemiological evidence suggests that the etiology of hormone receptor positive (HR+) breast cancer may differ by levels of histologic grade and proliferation. We pooled risk factor and pathology data on 5,905 HR+ breast cancer cases and 26,281 controls from 11 epidemiological studies. Proliferation was determined by centralized automated measures of KI67 in tissue microarrays. Odds ratios (OR), 95% confidence intervals (CI) and p-values for case-case and case-control comparisons for risk factors in relation to levels of grade and quartiles (Q1-Q4) of KI67 were estimated using polytomous logistic regression models. Case-case comparisons showed associations between nulliparity and high KI67 [OR (95% CI) for Q4 vs. Q1 = 1.54 (1.22, 1.95)]; obesity and high grade [grade 3 vs. 1 = 1.68 (1.31, 2.16)] and current use of combined hormone therapy (HT) and low grade [grade 3 vs. 1 = 0.27 (0.16, 0.44)] tumors. In case-control comparisons, nulliparity was associated with elevated risk of tumors with high but not low levels of proliferation [1.43 (1.14, 1.81) for KI67 Q4 vs. 0.83 (0.60, 1.14) for KI67 Q1]; obesity among women ≥50 years with high but not low grade tumors [1.55 (1.17, 2.06) for grade 3 vs. 0.88 (0.66, 1.16) for grade 1] and HT with low but not high grade tumors [3.07 (2.22, 4.23) for grade 1 vs. 0.85 (0.55, 1.30) for grade 3]. Menarcheal age and family history were similarly associated with HR+ tumors of different grade or KI67 levels. These findings provide insights into the etiologic heterogeneity of HR+ tumors.
Citation
International journal of cancer, 2018, 143 (4), pp. 746 - 757
Source Title
Publisher
WILEY
ISSN
0020-7136
eISSN
1097-0215
Research Team
Aetiological Epidemiology